Loading…
Hippocampal neurogenesis and pro‐neurogenic therapies for Alzheimer's disease
Adult hippocampal neurogenesis (AHN) facilitates hippocampal circuits plasticity and regulates hippocampus‐dependent cognition and emotion. However, AHN malfunction has been widely reported in both human and animal models of Alzheimer's disease (AD), the most common form of dementia in the elde...
Saved in:
Published in: | Animal models and experimental medicine 2022-02, Vol.5 (1), p.3-14 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Adult hippocampal neurogenesis (AHN) facilitates hippocampal circuits plasticity and regulates hippocampus‐dependent cognition and emotion. However, AHN malfunction has been widely reported in both human and animal models of Alzheimer's disease (AD), the most common form of dementia in the elderly. Pro‐neurogenic therapies including rescuing innate AHN, cell engraftment and glia‐neuron reprogramming hold great potential for compensating the neuronal loss and rewiring the degenerated neuronal network in AD, but there are still great challenges to be overcome. This review covers recent advances in unraveling the involvement of AHN in AD and highlights the prospect of emerging pro‐neurogenic remedies.
Innate AHN can be facilitated by pro‐neurogenic drugs, environmental enrichment combined with exercise, neurostimulation and dietary innervation. More extensive neurogenesis can be also induced by transplantation of stem cells or neural progenitors, as well as genetic induction of glia‐neuron conversion. |
---|---|
ISSN: | 2576-2095 2096-5451 2576-2095 |
DOI: | 10.1002/ame2.12212 |